Welcome to our dedicated page for 3M CO SEC filings (Ticker: MMM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on 3M CO's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into 3M CO's regulatory disclosures and financial reporting.
3M EVP & Chief HR Officer Zoe L. Dickson reported exercising a non-qualified stock option for 25,055 shares of common stock on February 9, 2026 at an exercise price of $102.89 per share. She then sold 25,055 common shares the same day at a weighted average price of $170.34 per share, with individual sale prices ranging from $170.16 to $170.47. Following these transactions, she directly owned 21,123.4401 common shares and indirectly held 299 shares through a 401k/paesop trust.
3M Company granted equity awards to its EVP and Chief Strategy Officer, Jonathan G. Van Wyck, on February 6, 2026. The grant includes 3,445 restricted stock units, each representing one share of 3M common stock, which vest 100% three years from the grant date.
He also received a non-qualified stock option for 14,913 shares of 3M common stock at an exercise price of $172.65 per share. These options vest in three equal annual installments on the first, second and third anniversaries of the grant date, and are held directly by him.
3M Company granted equity awards to executive Kevin H. Rhodes, EVP, Chief Legal Officer and Secretary. On February 6, 2026, he received 4,243 restricted stock units, each representing one share of 3M common stock, vesting 100% three years from the grant date.
He was also granted a non-qualified stock option for 18,367 shares of 3M common stock at an exercise price of $172.65 per share. This option vests in three equal annual installments starting one year after the grant date and expires on February 5, 2036. Both awards are reported as directly owned.
3M Company Sr Vice President & CAO Theresa E. Reinseth reported new equity awards dated February 6, 2026. She received 788 restricted stock units, each representing one share of 3M common stock, which vest 100% three years from the grant date.
She was also granted 1,706 non-qualified stock options with an exercise price of $172.65 per share. These options vest in three equal annual installments on the first, second, and third anniversaries of the grant date and are exercisable for 3M common stock through February 5, 2036.
3M executive Mark W. Murphy, EVP & Chief Info Digital Officer, received new equity awards in the form of restricted stock units and stock options.
On 02/06/2026, he was granted 2,915 restricted stock units, each representing a right to receive one share of 3M common stock. These units vest 100% three years from the grant date.
He was also granted 12,619 non-qualified stock options with an exercise price of $172.65 per share. These options will vest and become exercisable in three equal installments on each of the first, second, and third anniversaries of the 2026 grant date.
3M EVP & Chief Financial Officer Anurag Maheshwari received new equity awards. On 02/06/2026, he was granted 7,472 restricted stock units, each representing one share of 3M common stock, and 32,346 non-qualified stock options with a $172.65 exercise price.
The restricted stock units vest 100% three years from the grant date. The stock options vest in three equal annual installments on the first, second, and third anniversaries of the grant date, aligning his compensation with longer-term company performance.
3M Group President Christian T. Goralski Jr. reported new equity awards granted on February 6, 2026. He received 5,229 restricted stock units, each representing one share of 3M common stock, which vest 100% three years from the grant date.
He also received a non-qualified stock option covering 22,636 shares of 3M common stock, with an exercise price of $172.65 per share
3M Company executive Zoe L. Dickson, EVP & Chief HR Officer, reported new equity awards. On February 6, 2026, she received 3,122 restricted stock units, each representing one share of 3M common stock, which vest 100% three years from the grant date.
She was also granted a non-qualified stock option for 13,515 shares of 3M common stock at an exercise price of $172.65 per share. These options vest in three equal annual installments on the first, second, and third anniversaries of the grant date and expire on February 5, 2036.
3M Group President Paul Joseph Gallagher received new equity awards. On February 6, 2026, he was granted 3,910 restricted stock units, each representing a right to receive one share of 3M common stock, vesting 100% three years from the grant date.
He was also granted a non-qualified stock option for 16,925 shares of 3M common stock at an exercise price of $172.65 per share. This option will vest and become exercisable in three equal installments on the first, second, and third anniversaries of the grant date. Both awards are reported as directly owned.
3M executive Zoe L. Dickson, EVP & Chief HR Officer, reported stock transactions in common shares of 3M. On 02/09/2026, she exercised 20,519 shares of common stock at $142.94 per share, then sold 20,519 shares at a weighted average price of $169.97 per share.
After these transactions, Dickson directly beneficially owns 21,123.4401 shares of 3M common stock and indirectly owns 299 shares through a 401k/paesop Trust. The sale price reflects multiple trades between $169.91 and $170.15.